110 related articles for article (PubMed ID: 8402943)
1. Variants of vasoactive intestinal peptide in mouse mast cells and rat basophilic leukemia cells.
Wershil BK; Turck CW; Sreedharan SP; Yang J; An S; Galli SJ; Goetzl EJ
Cell Immunol; 1993 Oct; 151(2):369-78. PubMed ID: 8402943
[TBL] [Abstract][Full Text] [Related]
2. Structurally distinctive vasoactive intestinal peptides from rat basophilic leukemia cells.
Goetzl EJ; Sreedharan SP; Turck CW
J Biol Chem; 1988 Jul; 263(19):9083-6. PubMed ID: 3379062
[TBL] [Abstract][Full Text] [Related]
3. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP.
Lutz EM; Ronaldson E; Shaw P; Johnson MS; Holland PJ; Mitchell R
Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889
[TBL] [Abstract][Full Text] [Related]
4. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
5. Identification of an amino acid sequence in the laminin A chain mediating mast cell attachment and spreading.
Thompson HL; Burbelo PD; Yamada Y; Kleinman HK; Metcalfe DD
Immunology; 1991 Jan; 72(1):144-9. PubMed ID: 1997398
[TBL] [Abstract][Full Text] [Related]
6. Prepro-vasoactive intestinal polypeptide-derived peptide sequences in cerebral blood vessels of rats: on the functional anatomy of metabolic autoregulation.
Zhang ET; Mikkelsen JD; Fahrenkrug J; Møller M; Kronborg D; Lauritzen M
J Cereb Blood Flow Metab; 1991 Nov; 11(6):932-8. PubMed ID: 1939387
[TBL] [Abstract][Full Text] [Related]
7. Endogenous somatostatin-like peptides of rat basophilic leukemia cells.
Goetzl EJ; Chernov-Rogan T; Cooke MP; Renold F; Payan DG
J Immunol; 1985 Oct; 135(4):2707-12. PubMed ID: 2411811
[TBL] [Abstract][Full Text] [Related]
8. Hybrid resistance to parental bone marrow-derived cultured mast cells in the skin but not in the peritoneal cavity of (WB X C57BL/6)F1-W/Wv mice.
Nakano T; Waki N; Kanakura Y; Fujita J; Sonoda S; Asai H; Kitamura Y
Exp Hematol; 1988 Dec; 16(11):908-11. PubMed ID: 3181340
[TBL] [Abstract][Full Text] [Related]
9. High-affinity receptors for vasoactive intestinal peptide on human myeloma cells.
Finch RJ; Sreedharan SP; Goetzl EJ
J Immunol; 1989 Mar; 142(6):1977-81. PubMed ID: 2537866
[TBL] [Abstract][Full Text] [Related]
10. Mouse 3T3 fibroblasts induce rat basophilic leukemia (RBL-2H3) cells to acquire responsiveness to compound 48/80.
Swieter M; Midura RJ; Nishikata H; Oliver C; Berenstein EH; Mergenhagen SE; Hascall VC; Siraganian RP
J Immunol; 1993 Jan; 150(2):617-24. PubMed ID: 7678278
[TBL] [Abstract][Full Text] [Related]
11. Mast cells reduce survival of myenteric neurons in culture.
Sand E; Themner-Persson A; Ekblad E
Neuropharmacology; 2009 Feb; 56(2):522-30. PubMed ID: 19013185
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy.
Dvoráková MC; Pfeil U; Kuncová J; Svíglerová J; Galvis G; Krasteva G; König P; Grau V; Slavíková J; Kummer W
Cell Tissue Res; 2006 Mar; 323(3):383-93. PubMed ID: 16344947
[TBL] [Abstract][Full Text] [Related]
13. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway.
Yamashita K; Suzuki Y; Matsui T; Yoshimaru T; Yamaki M; Suzuki-Karasaki M; Hayakawa S; Shimizu K
Biochem Biophys Res Commun; 2000 Aug; 274(3):603-8. PubMed ID: 10924324
[TBL] [Abstract][Full Text] [Related]
15. Discovery and identification of serine and threonine phosphorylated proteins in activated mast cells: implications for regulation of protein synthesis in the rat basophilic leukemia mast cell line RBL-2H3.
Olson FJ; Ludowyke RI; Karlsson NG
J Proteome Res; 2009 Jun; 8(6):3068-77. PubMed ID: 19317463
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic variation in mast cell responsiveness to the inhibitory action of nitric oxide.
Koranteng RD; Dearman RJ; Kimber I; Coleman JW
Inflamm Res; 2000 May; 49(5):240-6. PubMed ID: 10893048
[TBL] [Abstract][Full Text] [Related]
17. Changing processes from bone marrow-derived cultured mast cells to connective tissue-type mast cells in the peritoneal cavity of mast cell-deficient w/wv mice: association of proliferation arrest and differentiation.
Nakano T; Kanakura Y; Asai H; Kitamura Y
J Immunol; 1987 Jan; 138(2):544-9. PubMed ID: 3794340
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
Igarashi H; Ito T; Pradhan TK; Mantey SA; Hou W; Coy DH; Jensen RT
J Pharmacol Exp Ther; 2002 Nov; 303(2):445-60. PubMed ID: 12388623
[TBL] [Abstract][Full Text] [Related]
19. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
[TBL] [Abstract][Full Text] [Related]
20. [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors.
Buku A; Condie BA; Price JA; Mezei M
J Pept Res; 2005 Sep; 66(3):132-7. PubMed ID: 16083440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
